Accelerating Peptide Discovery
Copyright 2012: CMD Bioscience. Computational Biotechnology. All rights reserved.
5 Science Park New Haven, CT 06511 203-298-4251 | info@cmdbioscience.com
CMD Bioscience News and Press Releases
January 2012: XXXXXXXXXXXXXXXX is appointed to Scientific Advisory Board.
January 2012: XXXXXXXXXXXXXXXX is appointed to Scientific Advisory Board.
October 2011: CMD Bioscience was named a "2011 Company to Watch" for the 2011 Cantor Colburn / CCAT Innovation and Entrepreneurship Summit, October 27, 2011 in New Haven, CT
September 2011: CMDBioscience will present at the Roche Colorado Corporation Peptide Symposium (RCCPS) 2011 in Boulder Colorado, September 11-14, 2011.
June 2011: CMD Bioscience to present aspects and work flows of CMDInventus highlighted in " Computational Prediction and Analysis of the DR6-NAPP interaction" at 22nd American Peptide Symposium in San Diego CA, June 25-30 2011.
June 2011: CMD Bioscience to present its CMDInventus Proof of Concept study " Using Modeling and de novo Peptide Design to Identify Novel, Optimizable, Broad-Spectrum and Specific Flavivirus Anti-Infectives: From Concept to Success in Eight Weeks" at 22nd American Peptide Symposium in San Diego CA, June 25-30 2011.
June 2011: CMD Bioscience LLC, announces launch of CMDInventus at 22nd American Peptide Symposium in San Diego CA, June 25-30 2011. Please stop by Exhibit Hall Booth #40
June 2011: CMD Bioscience LLC, accounces release of CMDInventus, a computational platform specifically developed to enable rational ( in silico) peptide discovery, screening, and optimization.
November 2010: CMD Bioscience LLC, achieves proof of concept for it's proprietary peptide computational discovery platform known as CMDInventus.
Dr Hruby is Regents Professor Emeritus in the Depts of Chemistry, Biochemistry and Molecular Biophysics, and Arizona ResearchLaboratories at the University of Arizona.
Dr. Beveridge is Professor of the Natural Sciences and Mathematics, and Professor of Chemistry and Director NIGMS Molecular Biophysics Training Program at Wesleyan University.
Dr. Trout is Professor of Chemical Engineering at MIT. He is currently Director of the Novartis-MIT Center for Continuous Manufacturing and Co-Chair of the Singapore-MIT Alliance Program on Chemical and Pharmaceutical Engineering.
Dr. Wolozin is a Professor of Pharmacology and Neurology at Boston University School of Medicine.
NEWS & EVENTS
CMD Bioscience Publications and Presentations
